Acumen Pharmaceuticals Inc (ABOS)
3.655
-0.08
(-2.01%)
USD |
NASDAQ |
May 17, 16:00
3.655
0.00 (0.00%)
After-Hours: 19:27
Acumen Pharmaceuticals Enterprise Value: -0.8153M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | -0.8153M |
| May 15, 2024 | 3.390M |
| May 14, 2024 | -3.218M |
| May 13, 2024 | -23.04M |
| May 10, 2024 | -23.04M |
| May 09, 2024 | -10.43M |
| May 08, 2024 | -20.64M |
| May 07, 2024 | -23.04M |
| May 06, 2024 | -11.03M |
| May 03, 2024 | -15.23M |
| May 02, 2024 | -15.84M |
| May 01, 2024 | -29.65M |
| April 30, 2024 | -31.46M |
| April 29, 2024 | -33.86M |
| April 26, 2024 | -34.46M |
| April 25, 2024 | -33.26M |
| April 24, 2024 | -33.86M |
| April 23, 2024 | -35.06M |
| April 22, 2024 | -36.86M |
| April 19, 2024 | -35.66M |
| April 18, 2024 | -35.06M |
| April 17, 2024 | -16.44M |
| April 16, 2024 | -14.63M |
| April 15, 2024 | -12.83M |
| April 12, 2024 | -0.2145M |
| Date | Value |
|---|---|
| April 11, 2024 | 8.797M |
| April 10, 2024 | -2.017M |
| April 09, 2024 | 5.793M |
| April 08, 2024 | 8.797M |
| April 05, 2024 | 6.394M |
| April 04, 2024 | 5.793M |
| April 03, 2024 | 9.999M |
| April 02, 2024 | 2.789M |
| April 01, 2024 | 16.01M |
| March 28, 2024 | 27.14M |
| March 27, 2024 | 30.14M |
| March 26, 2024 | 9.114M |
| March 25, 2024 | 39.15M |
| March 22, 2024 | 42.16M |
| March 21, 2024 | 43.96M |
| March 20, 2024 | 33.15M |
| March 19, 2024 | 15.46M |
| March 18, 2024 | 14.30M |
| March 15, 2024 | 25.88M |
| March 14, 2024 | 20.67M |
| March 13, 2024 | 35.73M |
| March 12, 2024 | 22.41M |
| March 11, 2024 | 31.67M |
| March 08, 2024 | 36.88M |
| March 07, 2024 | 36.88M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-107.72M
Minimum
Nov 09 2023
742.25M
Maximum
Jul 06 2021
104.17M
Average
38.54M
Median
Enterprise Value Benchmarks
| Accuray Inc | 278.78M |
| Kezar Life Sciences Inc | -113.75M |
| Akoya Biosciences Inc | 157.11M |
| NovaBay Pharmaceuticals Inc | 5.209M |
| Palatin Technologies Inc | 23.43M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.87M |
| Total Expenses (Quarterly) | 17.77M |
| EPS Diluted (Quarterly) | -0.25 |
| Earnings Yield | -29.00% |